Stabilized amorphous forms of Imatinib mesylate

Details for Australian Patent Application No. 2008262059 (hide)

Owner Novartis AG

Inventors Mutz, Michael; Wirth, Wolfgang; Lakshman, Jay Parthiban; Goncalves, Elisabete; Kalb, Oskar

Agent Davies Collison Cave

Pub. Number AU-B-2008262059

PCT Pub. Number WO2008/154262

Priority 60/974,197 21.09.07 US; 07109816.4 07.06.07 EP

Filing date 5 June 2008

Wipo publication date 18 December 2008

Acceptance publication date 5 April 2012

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/154262 Priority application(s): WO2008/154262

5 April 2012 Application Accepted

  Published as AU-B-2008262059

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262072-Removable injection or production flow equalization valve

2008262058-System and method for monitoring information related to sleep